Controversy over anti-psychotic drugs subsided

Jassen Korea and Lilly Korea have recently agreed that they will no longer argue over the indications and effects of their anti-psychotic drugs, Risperdal (risperidone) and Zyprexa (olanzapine).

The tentative decision of both firms to terminate the recent controversy of their anti-psychotic drugs is found in a consensus that the mutual slander may be detrimental to the development of the dom...